BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 240 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,481,000 | +4.8% | 16,410 | +1.0% | 0.03% | +13.0% |
| Q2 2022 | $2,367,000 | +25.3% | 16,245 | +1.9% | 0.02% | +53.3% |
| Q1 2022 | $1,889,000 | -13.5% | 15,935 | +0.6% | 0.02% | -11.8% |
| Q4 2021 | $2,183,000 | -1.5% | 15,842 | -0.7% | 0.02% | -5.6% |
| Q3 2021 | $2,216,000 | +55.6% | 15,953 | +8.8% | 0.02% | +50.0% |
| Q2 2021 | $1,424,000 | +40.4% | 14,664 | -1.1% | 0.01% | +33.3% |
| Q1 2021 | $1,014,000 | -19.6% | 14,831 | +0.8% | 0.01% | -18.2% |
| Q4 2020 | $1,261,000 | +29.2% | 14,713 | -2.0% | 0.01% | +10.0% |
| Q3 2020 | $976,000 | +19.3% | 15,012 | +34.3% | 0.01% | -16.7% |
| Q2 2020 | $818,000 | +130.4% | 11,182 | +7.3% | 0.01% | +100.0% |
| Q1 2020 | $355,000 | – | 10,425 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |